Mouth ulcers are open lesions and sores appearing in the mucous membrane of the oral cavity. Some mouth ulcers can be severe, which need immediate medical treatment for reduction of lesion and pain severity. Increasing use of chemicals in oral products, such as toothpaste and use of tobacco are major factors triggering recurrent mouth ulcers. Mouth ulcers are generally non-critical mucosal ulcers, formed mainly due to oral injuries to mucous membrane. The common causes of mouth ulcers are tissue injury, consumption of citric fruits, genetic tendency, allergy to various foods, nutritional problems, and impaired immune problems. Mouth ulcers can be prevented by avoiding tissue injury and maintaining oral hygiene.
Higher preference and easy availability of treatment products fuels the mouth ulcers treatment market
According to the British Dental Journal estimates of 2012, recurrent mouth ulcers affect 15% to 30% of the global population with frequency of 50% people from all age groups. The increasing awareness about the serious condition of mouth ulcers, extensive promotional activity programs, and easy availability of treatments products like gels and lozenges are estimated to fuel the growth of the global market in the forecast period. In addition, lack of knowledge of maintaining mouth hygiene and rising number of cases owing to the aging population are expected to accelerate the growth of the mouth ulcers market across the globe. Technical advancements in the field of dental care, rise in the use of pharmaceuticals for oral treatment fuel the market growth. The factors driving the global mouth ulcers treatment market are higher prevalence of mouth ulcers, increasing disease and treatment awareness, and rising adoption of pharmaceuticals as a treatment option. Gel formulations are the first line treatment largely prescribed to the patients owing to its ease of availability
The global mouth ulcers treatment market is segmented on the basis of drug type, formulation, indication and geography.
On the basis of drug type, the global mouth ulcers treatment market is segmented into:
On the basis of formulation, the global mouth ulcers treatment market is segmented into:
On the basis of indication, the global mouth ulcers treatment market is segmented into:
North America is expected to dominate the global market owing to the higher occurrence of aphthous stomatitis in women
Regional segmentation of the global mouth ulcers treatment market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East and Africa. According to the Journal of Oral Pathology and Medicine in 2013, around 49.7% women and 38.7% men were suffering from aphthous stomatitis in the U.S., thus increasing the demand of mouth ulcers treatment market in North America. North America dominates the market, due to augmented use of intra-oral cameras, digital X-rays, optical scanners, and computer assisted designs in the field of dentistry. Growing economies and demographics in the Asia Pacific is expected to boost the opportunities in this market.
The launch of new drugs is expected to trigger the demands for mouth ulcers treatment market
Rising number of mergers, acquisitions and new product launches are the latest trends adopted by the companies in the global mouth ulcers treatment market. Leading companies include Bristol-Myers Squibb Company, GlaxoSmithKline plc Pfizer, Inc., ECR Pharmaceuticals Co. Inc., Colgate-Palmolive Company.